Home › Glioma › Florida › Miami

Glioma clinical trials in Miami, FL

15 studies for Glioma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

RecruitingPhase 2

Miami Cancer Institute, Miami

Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

RecruitingPhase 1/2

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

12 Months – 21 Years · All sexes · Updated Sep 25, 2026 · NCT05099003

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RecruitingPhase 2

Nicklaus Children's Hospital, Miami

12 Months – 39 Years · All sexes · Updated Sep 21, 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study

University of Miami, Miami

12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2

University of Miami Hospital and Clinics, Miami

Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3

University of Miami Health, Miami

Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2

Nicklaus Children's Hospital, Miami

Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecruitingPhase 2

University of Miami Hospital and Clinics, Miami

Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

RecruitingPhase 2

BAPTIST ALLIANCE - MCI (Data Collection Only), Miami

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05188508

STARLITE for Unresectable High-Grade Gliomas

RecruitingPhase 1

University of Miami, Miami

Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06428045

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Recruiting

Miami Cancer Institute at Baptist Health, Inc., Miami

Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06397560

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

RecruitingPhase 2

University of Miami Hospital, Miami

Ages 18 to 75 · All sexes · Updated May 28, 2026 · NCT06264388

Non-invasive Glioma Characterization Through Molecular Imaging

Recruiting

University of Miami, Miami

Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT03684109

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

RecruitingPhase 1/2

University of Miami, Miami

Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06504381

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

RecruitingPhase 1/2

University of Miami Hospital, Miami

Up to age 18 · All sexes · Updated Nov 20, 2025 · NCT04299191

Glioma trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.